Viyash Scientific informs about investor presentation

06 Feb 2026 Evaluate
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Viyash Scientific has informed that it enclosed Investor Presentation on Unaudited Standalone and Consolidated Financial Results for the quarter ended December 31, 2025. 

The above information is a part of company’s filings submitted to BSE. 

Viyash Scientific Share Price

199.15 -9.90 (-4.74%)
06-Feb-2026 14:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.80
Dr. Reddys Lab 1235.60
Cipla 1325.25
Zydus Lifesciences 886.30
Lupin 2167.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×